BridgeMD
New treatment option for Binge-Eating Disorder
Official title Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
ClinicalTrials.gov ID: NCT06413433
What this study is testing
What is Solriamfetol 150 mg?
Solriamfetol 150 mg is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for binge-eating disorder.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- ENGAGE (Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol) is a Phase 3, randomized, double-blind, placebo-controlled, multicenter trial to assess the efficacy and safety of solriamfetol for the treatment of binge eating disorder (BED) in adults.
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 55
You may be able to join if
- Primary diagnosis of BED according to DSM-5 criteria.
- Provides written informed consent to participate in the study before the conduct of any study procedures.
- Male or female, aged 18 to 55 inclusive.
You likely can't join if
- Prior exposure to solriamfetol/Sunosi, through either a clinical study or prescription.
- Unable to comply with study procedures.
- Medically inappropriate for study participation in the opinion of the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Encino, California, United States
- Garden Grove, California, United States
- Long Beach, California, United States
- Newport Beach, California, United States
- San Diego, California, United States
- Santa Ana, California, United States
- Walnut Creek, California, United States
- West Covina, California, United States
- Colorado Springs, Colorado, United States
- Cromwell, Connecticut, United States
- Clermont, Florida, United States
- Fort Myers, Florida, United States
- Hialeah, Florida, United States
- Jacksonville, Florida, United States
- Lauderhill, Florida, United States
- Miami, Florida, United States
- Miami Lakes, Florida, United States
- Orlando, Florida, United States
- Marietta, Georgia, United States
- Overland Park, Kansas, United States
+ 22 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 55 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Encino, California, United States; Garden Grove, California, United States; Long Beach, California, United States; Newport Beach, California, United States; San Diego, California, United States; Santa Ana, California, United States and 36 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.